Pharmafile Logo

Early Pipeline Case Study

- PMLiVE

Lilly to invest $1.2bn in Puerto Rico manufacturing site

The investment will strengthen Lilly’s US manufacturing network

- PMLiVE

Doctored Truths urges pharma to lead the fight against health misinformation

“Doctored Truths” exposes the escalating crisis of health misinformation and disinformation, which has been ranked the world’s top short-term risk to the world, for the second year in a row....

Havas Lynx

- PMLiVE

Novartis presents new positive data for rheumatic autoimmune disease treatment

Patient outcome benefits were observed in two ongoing phase 3 trials

- PMLiVE

Novartis to acquire Avidity Biosciences in deal worth $12bn

The acquisition will expand Novartis’ neuroscience pipeline

- PMLiVE

BMS, Macmillan and 11 NHS Trusts publish report on cancer treatment prehabilitation

The report shows how prehabilitation can improve patient experience while alleviating capacity pressures

- PMLiVE

Corcept Therapeutics reports positive phase 3 results in ovarian cancer treatment

The company also plans to expand its phase 2 BELLA study to include three new study arms

- PMLiVE

ProImmune expands into new global headquarters in Oxford

The site offers capacity for both office accommodation and state-of-the-art laboratory facilities

Addressing the Mental Health Strain in Communications

As stress and burnout rise across UK communications, Fox&Cat’s Under the Tree sessions—now evolved into Minds on Matters—show how structured, skills-based support can reduce pressure and rebuild healthier working habits.

Fox&Cat

Putting the Best Minds on the Hardest Matters

Mental wellbeing is a defining challenge in health communications. High workloads, constant connectivity and leadership gaps are driving widespread burnout, with serious impacts on creativity, productivity and retention. Minds on...

Fox&Cat

- PMLiVE

Learn the golden standard for omnichannel strategies!

Tired of a fragmented omnichannel strategy that falls short of its promise? Join our free webinar to learn how to eliminate silos and turn fragmented data into actionable insights. Register...

Impetus Digital

- PMLiVE

Ipsen to acquire ImCheck Therapeutics in a deal worth up to €1bn

The acquisition includes a clinical stage acute myeloid leukaemia treatment currently in phase 1/2 trials

- PMLiVE

Excellence in Healthcare Partnerships Awards Networking Event

From plan to partnership: navigating the enablers and challenges of collaborative working

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links